Frontiers in Oncology

Frontiers in Oncology

Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study. György Rokszin, Zoltán Kiss, Gábor Sütő,...
Frontiers in Oncology

Frontiers in Oncology

Improving quality indicator of melanoma management – change of melanoma mortality-to-incidence rate ratio based on a Hungarian nationwide retrospective study. Máté Várnai, Zoltán Kiss, Rolland Gyulai, Judit Oláh, Péter Holló, Gabriella Emri, András Csejtei, István...
Pathology & Oncology Research

Pathology & Oncology Research

Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016. Gabriella Gálffy, Aladár Vastag, Krisztina Bogos, Zoltán Kiss, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Zoltán...
OncoTargets and Therapy

OncoTargets and Therapy

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience. Katalin Boér, Gábor Rubovszky, György Rokszin, Zsolt Abonyi-Tóth, Csenge Földesi and Magdolna Dank...
Pathology & Oncology Research

Pathology & Oncology Research

Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016. Lilla Tamási, Krisztián Horváth, Zoltán Kiss, Krisztina Bogos, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán...
Pathology & Oncology Research

Pathology & Oncology Research

Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016. Krisztina Bogos, Zoltan Kiss, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi,...